Retrospective Survey of Re-treatment With Bortezomib

NCT01524445 · clinicaltrials.gov ↗

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematological Cancer
Multiple Myeloma

Interventions

OTHER: bortezomib retreatment due to relapse

Sponsor

Janssen Pharmaceutica N.V., Belgium